NCT01363921

Effect of HCO1100 on Cardiovascular Function

Effect of High Cut-off Membranes on Cardiovascular Function in Patients With End-stage Renal Disease (HICOCARD)

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Vantive Health LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether high porous membranes are effective in the treatment of cardiovascular events in chronic dialysis patients.

Detailed description

Cardiovascular events are the leading cause of the increased mortality rate of chronic dialysis patients. It is believed that increased micro-inflammation plays an important role in the pathophysiological process of cardiovascular disease. High porous dialysis membranes can better eliminate inflammatory mediators as compared to standard dialysis membranes. In this study, the high porous dialysis membrane HCO1100 is investigated for its potential capability to improve the cardiovascular status of chronic dialysis patients.

Conditions

• Cardiovascular Disease
• Chronic Kidney Failure

Interventions

Type	Name	Description
DEVICE	HCO 1100	Dialysis treatment with HCO1100

Timeline

• Start date: 2011-04-01
• Primary completion: 2013-09-01
• Completion: 2013-09-01
• First posted: 2011-06-02
• Last updated: 2025-03-13

Locations

1 site across 1 country: Germany